Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas
- PMID: 14696593
- DOI: 10.1111/j.1365-2133.2003.05698.x
Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas
Similar articles
-
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.J Am Acad Dermatol. 2014 Feb;70(2):223.e1-17; quiz 240-2. doi: 10.1016/j.jaad.2013.08.033. J Am Acad Dermatol. 2014. PMID: 24438970 Review.
-
[Cutaneous lymphomas : Clinical presentation - diagnosis - treatment].Hautarzt. 2019 Oct;70(10):815-830. doi: 10.1007/s00105-019-04469-2. Hautarzt. 2019. PMID: 31511903 German.
-
[Cutaneous T-cell lymphoma].J Dtsch Dermatol Ges. 2003 Dec;1(12):965-80; quiz 981-2. doi: 10.1046/j.1439-0353.2003.03603.x. J Dtsch Dermatol Ges. 2003. PMID: 16285650 Review. German. No abstract available.
-
[Cutaneous lymphomas : Clinical presentation - diagnosis - treatment].Pathologe. 2020 Feb;41(1):79-94. doi: 10.1007/s00292-019-00743-1. Pathologe. 2020. PMID: 31932947 Review. German.
-
Cutaneous T-cell lymphoma (mycosis fungoides).Lancet. 1996 Mar 30;347(9005):871-6. doi: 10.1016/s0140-6736(96)91350-1. Lancet. 1996. PMID: 8622396 Review. No abstract available.
Cited by
-
Evaluation of Low-Dose, Low-Frequency Oral Psoralen-UV-A Treatment With or Without Maintenance on Early-Stage Mycosis Fungoides: A Randomized Clinical Trial.JAMA Dermatol. 2019 May 1;155(5):538-547. doi: 10.1001/jamadermatol.2018.5905. JAMA Dermatol. 2019. PMID: 30892603 Free PMC article. Clinical Trial.
-
Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management.Am J Hematol. 2016 Jan;91(1):151-65. doi: 10.1002/ajh.24233. Epub 2015 Nov 26. Am J Hematol. 2016. PMID: 26607183 Free PMC article. Review.
-
Mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL) epidemiology and treatment pathway in Spain: new insights for an accurate description.Drugs Context. 2020 Aug 5;9:2020-4-8. doi: 10.7573/dic.2020-4-8. eCollection 2020. Drugs Context. 2020. PMID: 32821261 Free PMC article.
-
Efficacy of ultraviolet A1 phototherapy in recalcitrant skin diseases.Ann Dermatol. 2010 Feb;22(1):1-8. doi: 10.5021/ad.2010.22.1.1. Epub 2010 Feb 28. Ann Dermatol. 2010. PMID: 20548873 Free PMC article.
-
Brentuximab Vedotin for Treating Relapsed or Refractory CD30-Positive Cutaneous T-Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.Pharmacoecon Open. 2020 Dec;4(4):563-574. doi: 10.1007/s41669-020-00203-0. Pharmacoecon Open. 2020. PMID: 32207075 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical